SEC Form 4 · accession 0001213900-15-004805
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas P Baker
Officer — Chief Financial Officer
Period of report
Jun 24, 2015
Accepted (ET)
Jun 26, 2015 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $1.05 | Jun 24, 2015 | J | 0 | A | May 12, 2015 | May 12, 2020 | Common Stock | 100,000 | 100,000 | D |
| Stock OptionF3 | $1.05 | May 24, 2015 | A | 100,000 | A | Dec 24, 2015 | Dec 24, 2020 | Common Stock | 100,000 | 200,000 | D |
Explanation of responses
- F1The Issuer repriced the exercise price of the option from $1.72 to $1.05.
- F2The Stock Options vested as to 50% of the shares on May 12, 2015 and 50% of the shares will vest on May 12, 2016.
- F3The Stock Options will vest as to 50% of the shares on December 24, 2015 and 50% of the shares on June 24, 2016.